ABVX
Price
$71.94
Change
+$0.17 (+0.24%)
Updated
Aug 1 closing price
Capitalization
5.5B
36 days until earnings call
VYNE
Price
$0.35
Change
-$0.02 (-5.41%)
Updated
Aug 1 closing price
Capitalization
5.88M
Interact to see
Advertisement

ABVX vs VYNE

Header iconABVX vs VYNE Comparison
Open Charts ABVX vs VYNEBanner chart's image
Abivax SA
Price$71.94
Change+$0.17 (+0.24%)
Volume$1.25M
Capitalization5.5B
VYNE Therapeutics
Price$0.35
Change-$0.02 (-5.41%)
Volume$2.96M
Capitalization5.88M
ABVX vs VYNE Comparison Chart in %
Loading...
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVX vs. VYNE commentary
Aug 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVX is a Buy and VYNE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2025
Stock price -- (ABVX: $71.94 vs. VYNE: $0.35)
Brand notoriety: ABVX and VYNE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVX: 83% vs. VYNE: 162%
Market capitalization -- ABVX: $5.5B vs. VYNE: $5.88M
ABVX [@Biotechnology] is valued at $5.5B. VYNE’s [@Biotechnology] market capitalization is $5.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVX’s FA Score shows that 0 FA rating(s) are green whileVYNE’s FA Score has 2 green FA rating(s).

  • ABVX’s FA Score: 0 green, 5 red.
  • VYNE’s FA Score: 2 green, 3 red.
According to our system of comparison, VYNE is a better buy in the long-term than ABVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVX’s TA Score shows that 3 TA indicator(s) are bullish while VYNE’s TA Score has 4 bullish TA indicator(s).

  • ABVX’s TA Score: 3 bullish, 3 bearish.
  • VYNE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ABVX is a better buy in the short-term than VYNE.

Price Growth

ABVX (@Biotechnology) experienced а +8.20% price change this week, while VYNE (@Biotechnology) price change was -75.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.14%. For the same industry, the average monthly price growth was +15.55%, and the average quarterly price growth was +36.18%.

Reported Earning Dates

ABVX is expected to report earnings on Sep 08, 2025.

VYNE is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+0.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABVX($5.5B) has a higher market cap than VYNE($5.88M). ABVX YTD gains are higher at: 882.855 vs. VYNE (-89.466). VYNE has higher annual earnings (EBITDA): -45.44M vs. ABVX (-170.04M). ABVX has more cash in the bank: 104M vs. VYNE (50.3M). VYNE has less debt than ABVX: VYNE (63K) vs ABVX (92.6M). VYNE has higher revenues than ABVX: VYNE (605K) vs ABVX (0).
ABVXVYNEABVX / VYNE
Capitalization5.5B5.88M93,470%
EBITDA-170.04M-45.44M374%
Gain YTD882.855-89.466-987%
P/E RatioN/A0.71-
Revenue0605K-
Total Cash104M50.3M207%
Total Debt92.6M63K146,984%
FUNDAMENTALS RATINGS
VYNE: Fundamental Ratings
VYNE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABVXVYNE
RSI
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 25 days ago
79%
Declines
ODDS (%)
Bearish Trend 23 days ago
87%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FND78.321.68
+2.19%
Floor & Decor Holdings
KAVL0.48N/A
+0.23%
Kaival Brands Innovations Group
SAGE8.68N/A
N/A
Sage Therapeutics
WRAP1.34-0.03
-2.19%
Wrap Technologies
ROCK64.32-1.71
-2.59%
Gibraltar Industries

ABVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with IMNN. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then IMNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
+0.24%
IMNN - ABVX
58%
Loosely correlated
+2.53%
CLSD - ABVX
52%
Loosely correlated
N/A
ANEB - ABVX
46%
Loosely correlated
+6.74%
MLTX - ABVX
39%
Loosely correlated
+4.92%
CGON - ABVX
38%
Loosely correlated
-1.42%
More

VYNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYNE has been loosely correlated with SYRE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if VYNE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYNE
1D Price
Change %
VYNE100%
-3.47%
SYRE - VYNE
36%
Loosely correlated
-4.18%
ABVX - VYNE
34%
Loosely correlated
+0.24%
EYPT - VYNE
32%
Poorly correlated
-1.12%
CRDF - VYNE
30%
Poorly correlated
+11.39%
SANA - VYNE
30%
Poorly correlated
-3.69%
More